Abstract
At the Pharmaceutical Regulatory Science Team (PRST) workshop on ICH Q9(R1), held at the Technological University Dublin in early June 2023, Boehringer Ingelheim US Biopharma Operations Product Management & Development Operations Head Emma Ramnarine shared her insights on balancing quality assurance and innovation in pharmaceutical manufacturing. She addressed: ● patient-centered transformation ● a watershed moment in her career ● understanding the drug shortage problem ● disruptive collaboration, and ● systems thinking
approaches. Click here for the slides accompanying Ramnarine’s remarks. She connected some of her remarks for the pharmaceutical industry to those made in the previous talk by Ed Hoffman, who was formerly the Chief Knowledge Officer for the US National Aeronautics and Space Administration (NASA). Formatting changes and other minor edits have been made for clarity by IPQ. Expressions of thanks to the meeting organizers/ attendees and disclaimers that the presentation represents the speaker’s views and not necessarily those of their organization are not included.
Recommended Citation
Ramnarine, Emma
(2023)
"Balancing Quality Assurance & Innovation in Pharma,"
Level 3:
Vol. 19:
Iss.
1, Article 3.
doi:https://doi.org/10.21427/q1nz-hm70
Available at:
https://arrow.tudublin.ie/level3/vol19/iss1/3
DOI
https://doi.org/10.21427/q1nz-hm70
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.